Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2021
TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC TreatmentMai Abdel Mouti, Siim PauklinTrends in Pharmacological Sciences|March 18, 2023
Chemically modified neoantigen-based immunotherapy for targeting KRASG12C-driven tumorsMai Abdel Mouti, Siim PauklinWiley Interdisciplinary Reviews. RNA|August 2, 2017
Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancerSarah Blagden, Mai Abdel Mouti, James ChettleOncotarget|May 12, 2016
Minimal contribution of ERK1/2-MAPK signalling towards the maintenance of oncogenic GNAQQ209P-driven uveal melanomas in zebrafishMai Abdel Mouti, Christopher Dee, Sarah E Coupland, et al.Nature Communications|September 14, 2023
KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristicsMai Abdel Mouti, Siwei Deng, Martin Pook, et al.RNA Biology|April 15, 2020
LARP1 isoform expression in human cancer cell linesHagen Schwenzer, Mai Abdel Mouti, Pia Neubert, et al.Biorxiv : the Preprint Server for Biology|March 13, 2023
BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinomaYuliang Feng, Liuyang Cai, Martin Pook, et al.Gastroenterology|September 22, 2023
BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal AdenocarcinomaYuliang Feng, Liuyang Cai, Martin Pook, et al.Pageof 1